Office of Pharmaceutical Science
Office of Testing & Research Director Ajaz Hussain, PhD, appointed Office of Pharmaceutical Science acting deputy director, effective April 9. Hussain will fill the position left vacant by Eric Sheinin's departure to the U.S. Pharmacopeia (1"The Pink Sheet" Jan. 8, p. 23). During Hussain's detail, Laboratory for Clinical Pharmacology Director Jerry Collins, PhD, will serve as the acting director of OTR
You may also be interested in...
Office of Pharmaceutical Science Deputy Director Eric Sheinin, PhD, will oversee the USP expert committees responsible for the General Chapters section of The U.S. Pharmacopeia in his new position as USP VP-general policy & requirements.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials